Clinical Trials for Esophageal Squamous Cell Carcinoma

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

NCT ID: NCT06056336

This clinical trial is exploring a treatment approach for patients with esophageal squamous cell carcinoma, a type of cancer that affects the throat. The study is looking at whether combining a new...

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

NCT ID: NCT06048926

Cadonilimab/Anlotinib in Locally Advanced or Relapsed/Metastatic ESCC Patients After Failure of PD-1 Combined With Platinum-containing Chemotherapy

NCT ID: NCT05990231

This clinical trial is studying a new treatment combination for patients with advanced esophageal squamous cell carcinoma (ESCC) who have not responded to initial therapy involving a PD-1 inhibitor...

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

NCT ID: NCT06020885

This clinical trial is exploring a new treatment approach for patients with a type of esophageal cancer called esophageal squamous cell carcinoma (ESCC) that cannot be surgically removed. The study...

Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell

NCT ID: NCT06006650

This clinical trial is looking at a new treatment approach for patients with stage II to IVA esophageal squamous cell carcinoma, which is a type of throat cancer. The study is testing whether a com...

Fruquintinib as First Line Treatment in Patients With Recurrent Esophageal Squamous Cell Carcinoma

NCT ID: NCT06010212

This clinical trial is investigating a new treatment approach for patients with advanced esophageal squamous cell carcinoma (ESCC), a type of cancer in the esophagus. The study will test a combinat...

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

NCT ID: NCT05978193

This clinical trial, called SCR-ESCC-01, is looking at how well combining low-dose and standard radiotherapy works with a type of immunotherapy for patients with advanced esophageal squamous cell c...

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

NCT ID: NCT05984342

This clinical trial is investigating whether a combination of chemotherapy and a treatment called Tislelizumab can help patients with a specific type of esophageal cancer, known as esophageal squam...

Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma

NCT ID: NCT03790553

This clinical trial is looking at two different doses of radiation therapy to find out which one works better for patients with locally advanced esophageal squamous cell carcinoma, a type of cancer...

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

NCT ID: NCT05281003

This clinical trial is studying the combination of pembrolizumab, an immunotherapy drug, with standard chemotherapy drugs (cisplatin and paclitaxel) as a treatment for patients with locally advance...

Efficacy Evaluation and Recurrence Monitoring of Therapy for Esophageal Squamous Cell Carcinoma Based on ctDNA-MRD.

NCT ID: NCT05900583

This clinical trial is studying a new way to monitor patients with locally advanced esophageal squamous cell carcinoma, a type of throat cancer, after they have received treatment and surgery. The ...

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

NCT ID: NCT05896787

This clinical trial is studying a new treatment called Candonilimab (also known as AK104) combined with standard preoperative chemotherapy for patients with locally advanced esophageal squamous cel...

Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

NCT ID: NCT05740995

This clinical trial is investigating the combination of a medication called anti-PD-1 and chemotherapy for patients with locally advanced esophageal squamous cell carcinoma, which is a type of canc...

Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC

NCT ID: NCT05775419

This clinical trial is studying the best treatment options for patients with a type of esophageal cancer called esophageal squamous cell carcinoma (ESCC), which affects the throat area and can be d...

Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients

NCT ID: NCT05252078

This clinical trial is investigating the effects of two medications, Anlotinib Hydrochloride Capsules and TQB2450 Injection, in patients with esophageal squamous cell carcinoma (ESCC) who have rece...

Patient-reported Outcomes in Preoperative Immunochemotherapy/Radiotherapy-treated Esophageal Cancer Patients

NCT ID: NCT05596890

This clinical trial is studying how well a combination of immunotherapy (a type of treatment that helps the immune system fight cancer) and chemotherapy (medications that kill cancer cells) works f...

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

NCT ID: NCT05594914

This clinical trial is studying a new treatment combination for patients with advanced esophageal squamous cell carcinoma, which is a type of cancer in the esophagus that can't be surgically remove...

Sintilimab Plus NCT or NCRT Versus NCRT for ESCC

NCT ID: NCT05244798

This clinical trial is studying a new treatment approach for patients with a type of esophageal cancer known as esophageal squamous cell carcinoma. The goal is to compare two treatment methods: one...

Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC

NCT ID: NCT05507411

This clinical trial is studying a new treatment approach for patients with esophageal squamous cell carcinoma (ESCC), a type of cancer in the esophagus. The goal is to see how effective a combinati...

Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy for Resectable Locally Advanced Esophageal Cancer (HCHTOG1903)

NCT ID: NCT04138212

This clinical trial is studying two different treatment approaches for patients with a type of esophageal cancer called locally advanced esophageal squamous cell carcinoma. Researchers want to find...